Liquid Biopsy Market: Shifting Paradigms in Cancer Screening and Monitoring | CAGR 20.9%
Liquid Biopsy Market– Global Outlook and Forecast 2023-2030 is latest research study released by Allied Market Research evaluating the market risk side analysis, highlighting opportunities and leveraged with strategic and tactical decision-making support (2023-2030). The market Study is segmented by key a region that is accelerating the marketization. The report provides information on market research and development, growth drivers, and the changing investment structure of the Global Liquid Biopsy Market. Some of the key players profiled in the study are Bio-Rad Laboratories, Biocept, Guardant Health, Illumina, F. Hoffmann-La Roche (FOUNDATION MEDICINE), Johnson & Johnson, Laboratory Corporation of America Holdings, MDxHealth, QIAGEN, Thermo Fisher Scientific. The global Liquid Biopsy market is estimated to reach at $6,804.90 million by 2028, registering a CAGR of 20.9% from 2021 to 2028.
Click To get FREE SAMPLE PDF (Including Full TOC, Table & Figures): https://www.alliedmarketresearch.com/request-sample/1891
Liquid Biopsy Market Outlook 2020-2030
The market is classified by product & service into three categories: kits & reagent, platforms & instruments, and services. In 2020, the kits & reagent segment generated the highest revenue due to the demand for reagents in liquid biopsy tests and their broad applicability.
In terms of circulating biomarkers, the market is divided into circulating tumor cell, extracellular vesicle, circulating tumor DNA, and other biomarkers. The circulating tumor cell (CTC) segment was the top revenue contributor in 2020, driven by promising clinical outcomes and widespread use in liquid biopsy-based cancer diagnosis. However, the circulating tumor DNA segment is projected to be the fastest growing during the forecast period, thanks to the rapid development of next-generation sequencing (NGS) technologies applied to circulating tumor DNA (ctDNA).
When it comes to cancer types, the market is segmented into lung cancer, breast cancer, colorectal cancer, prostate cancer, liver cancer, and others. The lung cancer segment held the largest share in 2020, primarily due to the high prevalence of non-small cell lung cancer (NSCLC) worldwide. According to the World Health Organization, there were approximately 1.80 million global deaths from lung cancer in 2020. On the other hand, the prostate cancer segment is expected to experience the highest growth rate during the forecast period. This is attributed to the increasing prevalence of prostate cancer in developed regions like North America.
In terms of end users, the market is categorized into hospitals & laboratories, and government & academic research centers. Among these, the hospital & laboratory segment is anticipated to dominate the liquid biopsy market. This is due to the extensive usage of liquid biopsy testing in hospital settings for cancer diagnosis.
Marketing Communication and Sales Channel
Understanding “marketing effectiveness” on a continual basis, help determine the potential of advertising and marketing communications and allow to use of best practices to utilize untapped audience. In order to make marketers make effective strategies and identify why the target market is not giving attention, we ensure the Study is Segmented with appropriate marketing & sales channels to identify potential market size by value & Volume* (if Applicable).
Have Any Query? Ask Our Expert @: https://www.alliedmarketresearch.com/purchase-enquiry/1891
The segments and sub-section of Liquid Biopsy market is shown below:
By Product & Service: Kits & Reagents, Platforms & Instruments, and Services
By Circulating Biomarker: Circulating Tumor Cells, Extracellular Vesicles, Circulating Tumor DNA [ctDNA], and Other Biomarkers
By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, and Other Cancers
By End User: Hospitals & Laboratories and Government & Academic Research Centers
Some of the key players involved in the Market are: Bio-Rad Laboratories, Biocept, Guardant Health, Illumina, F. Hoffmann-La Roche (FOUNDATION MEDICINE), Johnson & Johnson, Laboratory Corporation of America Holdings, MDxHealth, QIAGEN, Thermo Fisher Scientific.
Important years considered in the Liquid Biopsy study:
Historical year – 2017-2021; Base year – 2021; Forecast period** – 2022 to 2030 [** unless otherwise stated]
If opting for the Global version of Liquid Biopsy Market; then below country analysis would be included:
– North America (USA, Canada and Mexico)
– Europe (Germany, France, the United Kingdom, Netherlands, Italy, Nordic Nations, Spain, Switzerland and Rest of Europe)
– Asia-Pacific (China, Japan, Australia, New Zealand, South Korea, India, Southeast Asia and Rest of APAC)
– South America (Brazil, Argentina, Chile, Colombia, Rest of countries etc.)
– Middle East and Africa (Saudi Arabia, United Arab Emirates, Israel, Egypt, Turkey, Nigeria, South Africa, Rest of MEA)
Introduction about Liquid Biopsy Market
Liquid Biopsy Market Size (Sales) Market Share by Type (Product Category)
Liquid Biopsy Market by Application/End Users
Liquid Biopsy Sales (Volume) and Market Share Comparison by Applications
Global Liquid Biopsy Sales and Growth Rate (2020-2030)
Liquid Biopsy Competition by Players/Suppliers, Region, Type, and Application
Liquid Biopsy (Volume, Value, and Sales Price) table defined for each geographic region defined.
Liquid Biopsy Players/Suppliers Profiles and Sales Data
Key Raw Materials Analysis & Price Trends
Supply Chain, Sourcing Strategy and Downstream Buyers, Industrial Chain Analysis
……..and view more in complete table of Contents
Procure Complete Report (220+ Pages PDF with Insights, Charts, Tables, and Figures) @ https://www.alliedmarketresearch.com/checkout-final/f9bc273ee201996696fdec7d3e59f3e4
Thanks for reading this article; you can also get an individual chapter-wise sections or region-wise report versions like North America, LATAM, Europe, or Southeast Asia.
Read More Trending Reports Here:
Filgrastim Market by Drug Type (Biologic and Biosimilar), Indication (Chemotherapy induced Neutropenia, Chronic Neutropenia and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies): Global Opportunity Analysis and Industry Forecast, 2021-2030
Companion Diagnostics Market Size, Share, Growth & Segmentation By Technology Type (Immunohistochemistry, Polymerase Chain Reaction [PCR], Next Generation Sequencing [NGS], In Situ Hybridization, and Others), and Indication (Oncology, Neurology, and Others): Global Opportunity Analysis and Industry Forecast, 2021-2030
Dermatologicals Market by Disease (Acne, Dermatitis, Psoriasis, Skin Cancer, Rosacea, Alopecia, and Others), Type (Prescription-based Drugs, and Over-the-Counter Drugs), and Route of Administration (Topical Administration, Oral Administration, and Parenteral Administration): Global Opportunity Analysis and Industry Forecast, 2021-2030
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Contact Us:
David Correa
Portland, OR, United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022,
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
Editor Details
-
Company:
- The Wire Times
